SKShay-Whey Margaret Koh

Shay-Whey Margaret Koh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shay-Whey Margaret Koh has a total of 21 co-authors. Here are the top co-authors by number of shared publications:

  • Timothy J. Coll

    Department of Ophthalmology and Visual Sciences, University of Maryland, Baltimore, Maryland

    3 shared publications
  • Allan R. Rutzen

    Department of Ophthalmology and Visual Sciences, University of Maryland, Baltimore, Maryland

    2 shared publications
  • Cara J. Abbondandolo

    Departments of Ophthalmology & Visual Sciences and Physiology, University of Maryland, Baltimore, Maryland

    2 shared publications
  • Eve J. Higginbotham

    Department of Ophthalmology, University of Maryland, Baltimore, Maryland, USA

    2 shared publications
  • Aviva J. Symes

    Department of Pharmacology and Molecular Therapeutics, Uniformed Services University, Bethesda, MD, United States

    1 shared publication
  • Beatrice Y.J.T. Yue

    1 shared publication

Latest Publications

  • Open Access

    Corneal Endothelial Autocrine VIP Enhances Its Integrity in Stored Human Donor Corneoscleral Explant

    by Shay-Whey M. Koh, Dante Gloria, Joseph Molloy

    Purpose.: To demonstrate corneal endothelial (CE) integrity enhanced during eye banking by a brief treatment of human donor corneoscleral explant (explant) with CE autocrine trophic factor vasoactive intestinal peptide (VIP). Methods.: Paired explants were used as control versus VIP (10 nM)-treated before storage in corneal storage medium (4°C). CE ciliary neurotrophic factor receptor (CNTFRα) and CNTF (0.83 nM) responsiveness in connexin 43 upregulation were monitored (Western blot analysis). CE damage in CNTF-modulated explants and corneal buttons from explants was quantified by analysis of panoramic and microscopic images of the alizarin red-stained corneal endothelium. CE cells scraped from the Descemet's membrane were counted. CE VIP receptor was demonstrated (Western blot analysis). Results.: CE cells in every VIP-treated, freshly dissected explant demonstrated higher CNTFRα levels than controls (100% vs. 142% ± 15%; P = 0.014; 7 pairs stored for 4 to 25 days). Nine days after VIP treatment of previously preserved explants, CNTF responsiveness was 174% ± 23% (P = 0.023; 4 pairs) of controls. Panoramic images of explants and corneal buttons revealed that VIP treatment reduced CE damage to 75% ± 6% (P = 0.023; 4 pairs) and 71% ± 11% (P = 0.016; 9 pairs) of controls, respectively, whereas CE damage to 39% (2 pairs) and 23% ± 4% (P < 0.001; 7 pairs), respectively, was revealed in microscopic images. Twenty-one days after VIP treatment of previously preserved explants, CE cell retention was 206% ± 38% (P = 0.008; 14 pairs) of the control. CE cells from human donor corneas expressed VIP receptor VPAC1 (not VPAC2). Conclusions.: CE integrity during eye banking was enhanced by a brief treatment of the explant with the CE autocrine VIP.


  • Open Access

    VIP down‐regulates the inflammatory potential and promotes survival of dying (neural crest‐derived) corneal endothelial cells ex vivo: necrosis to apoptosis switch and up‐regulation of Bcl‐2 and N‐cadherin

    by Shay‐Whey M. Koh, Jason Cheng, Rebecca M. Dodson, Chao‐Yar T Ku, Cara J. Abbondandolo

    J. Neurochem. (2009) 109, 792–806. Abstract The neuropeptide vasoactive intestinal peptide (VIP) is anti-inflammatory and protective in the immune and nervous systems, respectively. This study demonstrated in corneal endothelial (CE) cells injured by severe oxidative stress (1.4 mM H2O2) in bovine corneal organ cultures that VIP pre-treatment (0, 10−10, 10−8, and 10−6 M; 15 min), in a VIP concentration-dependent manner, switched the inflammation-causing necrosis to inflammation-neutral apoptosis (showing annexin V-binding, chromatin condensation, and DNA fragmentation) and upheld ATP levels in a VIP antagonist (SN)VIPhyb-sensitive manner, while up-regulated mRNA levels of the anti-apoptotic Bcl-2 and the differentiation marker N-cadherin in a kinase A inhibitor-sensitive manner. As a result, VIP, in a concentration-dependent and VIP antagonist-sensitive manners, promoted long-term CE cell survival. ATP levels, a determining factor in the choice of apoptosis versus necrosis, measured after VIP pre-treatment and 0.5 min post-H2O2 were 39.6 ± 3.3, 50.8 ± 6.2, 60.1 ± 4.8, and 53.6 ± 5.3 pmoles/μg protein (mean ± SEM), respectively (p < 0.05, anova). VIP treatment alone concentration-dependently increased levels of N-cadherin ( Koh et al. 2008 ), the phosphorylated cAMP-responsive-element binding protein and Bcl-2, while10−8 M VIP, in a VIP antagonist (SN)VIPhyb-sensitive manner, increased ATP level by 38% (p < 0.02) and decreased glycogen level by 32% (p < 0.02). VPAC1 (not VPAC2) receptor was expressed in CE cells. Thus, CE cell VIP/VPAC1 signaling is both anti-inflammatory and protective in the corneal endothelium.


  • Functional CNTF Receptor α Subunit Restored by Its Recombinant in Corneal Endothelial Cells in Stored Human Donor Corneas: Connexin-43 Upregulation

    by Shay-Whey M. Koh, Jordan Celeste, C. Y. Paul Ku

    Purpose. Ciliary neurotrophic factor (CNTF) is undergoing testing in human clinical trials to rescue degenerating retina, whereas studies show that the CNTF-binding α-subunit of the CNTF receptor (CNTFRα) is released from injured tissues. Here, the recombinant human (rh) CNTFRα was shown to restore functional CNTFRα in human corneal endothelial (CE) cells that lost endogenous CNTFRα during corneal storage


  • Open Access

    VIP and VIP Gene Silencing Modulation of Differentiation Marker N-Cadherin and Cell Shape of Corneal Endothelium in Human Corneas Ex Vivo

    by Shay-Whey M. Koh, Krish Chandrasekara, Cara J. Abbondandolo, Timothy J. Coll, Allan R. Rutzen

    Purpose. Vasoactive intestinal peptide (VIP) is expressed by corneal endothelial (CE) cells and is present in the aqueous humor, which bathes CE cells in vivo. This study demonstrated the role of CE cell VIP in maintaining the expression level of a CE differentiation marker, N-cadherin, and the hexagonal cell shape. methods. To determine the most effective VIP concentration, bovine corneoscleral explants were treated with 0 (control) and 10−12 to 10−6 M VIP. Paired human corneas (nine donors) from an eye bank were used as control; the other corneas were treated with VIP. To silence endogenous VIP, paired fresh human donor corneas (from seven cadavers) were transduced with VIP shRNA or the control lentiviral particles and then bisected/quartered for quantitative analysis by semiquantitative RT-PCR (for mRNA) and Western blot analysis/immunocytochemistry (for protein), whereas alizarin red S staining revealed CE cell shape. results. VIP concentration dependently increased bovine CE cell N-cadherin mRNA levels, with the maximal effect observed between 10−10 (1.47 ± 0.06-fold; P = 0.002) and 10−8 M VIP (1.48 ± 0.18-fold; P = 0.012). VIP (10−8 M) treatment increased N-cadherin protein levels in bovine and human CE cells to 1.98 ± 0.28-fold (P = 0.005) and 1.17 ± 0.10 (range, 0.91–1.87)-fold (P = 0.050) of their respective controls. VIP antagonist (SN)VIPhyb diminished the VIP effect. VIP silencing resulted in deterioration of the hexagonal cell shape and decreased levels of VIP protein and mRNA, N-cadherin (but not connexin-43) mRNA and protein, and the antiapoptotic Bcl-2 protein. conclusions. Through its autocrine VIP, CE cells play an active role in maintaining the differentiated state and suppressing apoptosis in the corneal endothelium in situ.


  • Vasoactive intestinal peptide induction by ciliary neurotrophic factor in donor human corneal endothelium in situ

    by Shay-Whey M. Koh, Yan Guo, Steve L. Bernstein, James A. Waschek, Xiuhuai Liu, Aviva J. Symes


  • VIP Immunoreactivity in Human Aqueous Humor

    by Shay-Whey M. Koh, Allan R. Rutzen, Timothy J. Coll, Ramzi K. Hemady, Eve J. Higginbotham

    Purpose: To demonstrate the presence of vasoactive intestinal peptide (VIP)-immunoreactive molecule in the human aqueous humor collected from eyes undergoing either cataract or glaucoma surgeries and to identify the masses of molecules responsible for the VIP immunoreactivity. Methods: Aqueous humor specimens were collected by parencentesis from nine cataract patients and also from eight patients undergoing glaucoma surgery following the creation of the limbal based conjunctival flap, partial dissection of the scleral flap, and application of mitomycin-C. The aqueous humor specimens were analyzed by radioimmunoassay to determine the level of VIP immunoreactivity. Specimens from 10 other cataract patients were pooled and analyzed for VIP immunoreactivity by Western blot analysis.Results: Levels of VIP immunoreactivity in aqueous humor of cataract and glaucoma patients were significantly different and were 610 ± 160 and 260 ± 64 pg VIP/ml, respectively (p = 0.03), while there was no correlation between the donor age and the level of VIP immunoreactivity. VIP immunoreactivity was detected as a single molecule with a molecular weight of 9000. Conclusions: The disease status and the treatments of the eye that led to surgery and procedures applied to the eye immediately before aqueous humor collection, but not the age of the patients, affected the level of VIP immunoreactivity in the aqueous humor. The relationship between the 9000 Da VIP-immunoreactive molecule and the authentic (3326 Da) VIP remains to be studied.


  • Antiglaucoma Eye Drop Pulses???Increased Interleukin-6 Secretion by Tenon???s Capsule Fibroblast Cultures

    by Shay-Whey M. Koh, Timothy J. Coll, Linda Rose, Yukihiro Matsumoto, Eve J. Higginbotham

    Long-term antiglaucoma eye drop therapy prior to trabeculectomy is a risk factor for surgical failure resulting from Tenon’s capsule fibrosis at the fistula site. The study tested the hypothesis that secretion of the proinflammatory cytokine interleukin (IL)-6 by wounded Tenon’s capsule-fibroblasts is elevated by prior long-term antiglaucoma eye drop treatment. Fibroblast cultures were established from Tenon’s capsule biopsies during trabeculectomy. Twice daily and for four and a half days, confluent secondary (2–4 passages) cultures were treated (30 minutes at 37°C) with the following drugs (diluted at 1:400–1:100): 0.2% brimonidine-tartrate (Alphagan), 2.0% dorzolamide-HCl (Trusopt), 0.5% timolol-maleate (Timoptic), 2.0% dorzolamide-HCl/0.5% timolol-maleate (Cosopt), 2 and 4% pilocarpine-HCl (Akarpine and Pilocar), 0.005% latanoprost (Xalatan), placebos for Trusopt and Timoptic, and 0.01% benzalkonium chloride. Subsequently, cultures were wounded by removing cells grown on half of each culture dishes along with the medium and conditioned for 20 hours in serum-free growth medium, which was then collected for ELISA for IL-6 (and TNF-α and IL-1β). Cultures were grown for four additional days to show the maintenance of culture sterility. Latanoprost, pilocarpine-HCl, and timolol-maleate increased IL-6 levels in the conditioned medium in a dilution factor-dependent manner (P < 0.05, ANOVA). IL-6 concentrations were increased most significantly by latanoprost and were (pg/ml; mean ± SEM; N = 3 cultures) 186 ± 37, 187 ± 33, 295 ± 46 and 336 ± 76 in cultures treated at 1:400, 1:250, 1:150, and 1:100 dilutions, respectively, whereas those of six control cultures averaged 80 ± 9. Benzalkonium chloride, brimonidine-tartrate, dorzolamide-HCl, Cosopt placebo, Timoptic placebo, and dorzolamide-HCl/timolol-maleate did not significantly elevate IL-6 concentrations. IL-1β and TNF-α were not detected in the medium of control cultures and those treated with pilocarpine (1:200). The present study demonstrated for the first time that the level of IL-6 secretion by wounded Tenon’s capsule fibroblast cell cultures was increased by repeat pulsing of these cultures with some, but not all, antiglaucoma eye drops prior to wounding.


    • 1 September 2002
      • Vol. 43  (9) , 2887-96

    Ciliary neurotrophic factor released by corneal endothelium surviving oxidative stress ex vivo.

    by Shay-Whey M Koh

    To demonstrate that corneal endothelial (CE) cells that survive oxidative stress in corneas release ciliary neurotrophic factor (CNTF), which does not possess the secretion signal sequence. CNTF and CNTF receptor alpha subunit (CNTFRalpha) in CE cells and cell-conditioned medium (H2O2 and PBS placed in bovine corneal cups for 30 minutes at 37 degrees C) in explant cultures were demonstrated by Western blot (WB) and immunoprecipitation (IP). The number of dead CE cells was determined microscopically with a viability kit, by an observer uninformed of the explants' identities. CNTF and CNTFRalpha synthesis and release by CE cells in 35S-methionine-labeled (0.1 mCi/mL for 8 hours at 37 degrees C) corneal cups were shown by autoradiography and WB. RESULTS. CE cells in fresh bovine eyes expressed a 25-kDa CNTF that was recognized by three different antibodies. CE cells expressed a 61-kDa CNTF-immunoreactive molecule (IM), which disappeared from the CE cells in H2O2-conditioned corneal cups, concomitant with the appearance of the 25-kDa CNTF in the conditioned medium. Corneal cups containing 0, 0.006, 0.012, 0.023, 0.045, 0.09, 0.18, and 0.35 mM H2O2 demonstrated relative levels of CE cell 61-kDa CNTF-IM of 100%, 84%, 77%, 61%, 52%, 39%, 35%, and 35%, respectively, whereas levels of 25-kDa CNTF in the conditioned medium were 23%, 32%, 39%, 63%, 80%, 90%, 100%, and 63%, respectively. CE cells expressed a 53-kDa CNTFRalpha that, along with trace amounts of a 61-kDa CNTFRalpha-IM, appeared concomitantly with the 25-kDa CNTF in the conditioned medium. H2O2 (0-0.56 mM) did not affect the viability of CE cells (15 dead cells per 600 cells). CE cells in 35S-methionine-labeled corneal cups synthesized and released a 35S 61-kDa molecule that was both CNTF- and CNTFRalpha-immunoreactive in an H2O2-dependent manner, whereas 25-kDa CNTF was detected in the (35)S-methionine labeling medium. CE cells release autocrine CNTF under sublethal oxidative stress by a mechanism that involves CNTFRalpha and the formation of a 61-kDa CNTF/CNTFRalpha-IM.


  • VIP Stimulation of cAMP Production in Corneal Endothelial Cells in Tissue and Organ Cultures

    by Shay-Whey M. Koh, Beatrice Y.J.T. Yue

    To demonstrate that vasoactive intestinal peptide (VIP), an immunosuppressive factor found in the aqueous humor, is a modulator of the corneal endothelium (CE) stimulating its intracellular cAMP production. Rabbit CE cells in cell culture and CE cells in cornea cup organ cultures established from bovine and human donor eyes were treated with VIP at varying concentrations (0, 10−11–10−6mol/L) for a constant time (4 minutes) or varying times (1, 3.25, 10, 15 minutes) at a constant concentration (1 × 10−6mol/L). Intracellular cAMP was extracted and its concentrations were determined by radioimmunoassay. Agonists that are known to modulate the intracellular cAMP concentrations of target cells were allowed to react with cultured rabbit CE cells at 1 × 10−6mol/L for 4 minutes. Vasoactive intestinal peptide stimulated the intracellular cAMP production in CE cells in a dose- and time-dependent manner. At concentrations lower than 10−9mol/L, VIP showed little effect. Treatment with 10−8, 10−7, and 10−6mol/L VIP for 4 minutes, however, increased the intracellular cAMP by 5.7-, 12.3-, and 9.5-fold, respectively, compared with the basal level in rabbit CE cell cultures, and by 19.5-, 38.7-, and 23.3-fold, respectively, in CE cells in bovine cornea cups. The effect of VIP was confirmed in two pairs of donor human corneas in which an average of 2.7-fold stimulation by 5 × 10−7mol/L was observed. Treatment of rabbit CE cells with 1 × 10−6mol//L VIP for 1 to 15 minutes elevated the intracellular cAMP level by six- to 69-fold. Among the agonists tested, α-melanocyte-stimulating hormone and glucagon were not effective, whereas l-isoproterenol and prostaglandin E1were capable of stimulating the intracellular cAMP levels in rabbit CE cells. The current study demonstrated that VIP stimulated cAMP production in CE cells, similar to that shown previously in trabecular meshwork and nonpigmented ciliary epithelial cells. Tissues bathed in the aqueous humor are thus responsive to VIP modulation.